Graham Home Care Limited has been acquired by Carewatch Care Services Limited
Graham Home Care, a domiciliary care business has been sold to Carewatch Care Services Limited, who are backed by Lyceum Capital, for an undisclosed consideration.
Graham Home Care was formed in 1996 to provide home based social care services. From that small beginning, Graham Home Care has grown significantly becoming the largest and most established Carewatch franchisee in the UK with nine franchises.
Oaklins Smith & Williamson, based in the UK, acted as corporate finance, accounting and tax advisors to Graham Home Care. The team's specialist commented: “There has been considerable activity in the care sector market recently and this was another transaction we have been pleased to work on. Graham Home Care has been a long term client of ours and we are delighted to have helped Sally and her father move onto the next stage of their lives.”


Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more